Skip to content

R&D at other companies

Stryker logo
StrykerSYK
$413M+2.0%
Coherent logo
CoherentCOHR
$185.99M+23.4%
Intuitive Surgical logo
Intuitive SurgicalISRG
$361.9M+14.5%
Onto Innovation logo
Onto InnovationONTO
$35.1M+25.2%
Belden logo
BeldenBDC
$30.09M+5.9%
Regal Rexnord logo
Regal RexnordRRX
$49.68M+12.6%

Segments

By segment

See full
Medical Solutions$14.25M+2.1%
Automation Enabling Technologies$9.03M-4.3%

Other financials

Income statement

See full
Revenue$257.7M+10.4%
Gross profit$113.6M+8.8%
Operating income$27.5M-15.1%
Net income$21.1M-0.5%
EPS (diluted)$0.51-13.6%

Balance sheet

See full
Cash & equivalents$388.8M+267%
Total debt$291.3M-34.2%
Total equity$1.3B+70.3%
Total assets$1.8B+29.9%

Cash flow

See full
Operating cash flow$51.6M+62.9%
CapEx$4.1M-3.4%
Free cash flow$47.5M+73.2%

Valuation

See full
Market cap$5.53B-8.3%

Profitability

See full
Gross margin44.2%-0.5pp
Operating margin8.9%-3.5pp
Net margin5.3%-2.1pp
FCF margin6.8%-8.1pp

Returns & leverage

See full
Return on equity5.2%-4.6pp
Debt / equity0.2×-0.4×
Current ratio3.6×+1.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novanta's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novanta's R&D?
Novanta (NOVT) reported R&D of $23.25M in Q1 2026.
How has Novanta's R&D changed year-over-year?
Novanta's R&D increased by 0.1% year-over-year, from $23.24M to $23.25M.
What is the long-term trend for Novanta's R&D?
Over 4 years (2021 to 2025), Novanta's R&D has grown at a 7.1% compound annual growth rate (CAGR), from $72.52M to $95.48M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.